AFP and neoplasm: The combination of dynamic changes of tumor response to downstaging by radiological mRECIST classification and AFP levels might be able to better refine patient selection before and during downstaging procedures, especially since progressive disease during downstaging is a worse prognostic factor in patients outside MC.